These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

68 related articles for article (PubMed ID: 209402)

  • 1. [In vitro activity of ornidazole against anaerobic organisms. Differences seen in certain strains in relation to the partial pressure of oxygen. (author's transl)].
    Peloux Y; Giacchero E
    Nouv Presse Med; 1978 May; 7(18):1562. PubMed ID: 209402
    [No Abstract]   [Full Text] [Related]  

  • 2. ["In vitro" susceptibility of some aerobic and anaerobic bacteria to three 5-nitro-imidazole derivatives: metronidazole, ornidazole and tinidazole (author's transl)].
    Dublanchet A; Durieux R
    Ann Microbiol (Paris); 1980; 131(1):45-59. PubMed ID: 7362180
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Efficacy of tinidazole against anaerobes in comparison with metronidazole, ornidazole, cefoxitin and lamoxactam].
    Werner H; Kuchenbecker K; Hammann R
    Immun Infekt; 1983 Jun; 11(4):143-7. PubMed ID: 6681175
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Antimicrobial activity of ornidazole and 6 other antibiotics against anaerobic bacteria].
    Alados JC; Martínez-Brocal A; Miranda C; Rojo MD; García V; Domínguez MC; de la Rosa M
    Enferm Infecc Microbiol Clin; 1991 Apr; 9(4):219-22. PubMed ID: 1863621
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In vitro susceptibility of anaerobic bacteria to nitroimidazoles.
    Olsson-Liljequist B; Nord CE
    Scand J Infect Dis Suppl; 1981; 26():42-5. PubMed ID: 6941455
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Cytomorphological study of the action of ornidazole against Bacteroides fragilis].
    Attisso MA; Dusart G; Simeon De Buochberg M; Zuccarelli M
    Pathol Biol (Paris); 1987 Jun; 35(5 Pt 2):813-8. PubMed ID: 3309820
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nitroimidazoles, Part XXIII--activity of satranidazole series against anaerobic infections.
    Nagarajan K; Gowrishankar R; Arya VP; George T; Nair MD; Shenoy SJ; Sudarsanam V
    Indian J Exp Biol; 1992 Mar; 30(3):193-200. PubMed ID: 1512026
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Susceptibility of anaerobic bacteria to cefoxitin (author's transl)].
    Freydière AM; Gille Y; Marcel JP; Vincent P
    Sem Hop; 1980 Nov 18-25; 56(43-44):1793-5. PubMed ID: 6256880
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bactericidal activity of metronidazole, tinidazole and ornidazole against Bacteroides fragilis in vitro.
    Jokipii L; Jokipii AM
    J Antimicrob Chemother; 1977 Nov; 3(6):571-7. PubMed ID: 599119
    [No Abstract]   [Full Text] [Related]  

  • 10. [In vitro activity of cefotaxime on anaerobes (author's transl)].
    Soussy CJ; Thibault M; Duval J
    Nouv Presse Med; 1981 Feb; 10(8):556-8. PubMed ID: 6259592
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nitroimidazoles: in vitro activity and efficacy in anaerobic infections.
    Tally FP; Goldin B; Sullivan NE
    Scand J Infect Dis Suppl; 1981; 26():46-53. PubMed ID: 6941456
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ornidazole and anaerobic bacteria: in vitro sensitivity and effects on wound infections after appendectomy.
    Palmu A; Renkonen OV; Aromaa U
    J Infect Dis; 1979 May; 139(5):586-9. PubMed ID: 220342
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The in-vitro activity of three long-acting cephalosporins against Bacteroides fragilis, Peptostreptococcus species and Clostridium perfringens.
    Watt B; Naden MG
    Chemioterapia; 1988 Aug; 7(4):264-6. PubMed ID: 2902937
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Activity of cefotetan against anaerobic bacteria].
    Sedallian A
    Pathol Biol (Paris); 1986 Jun; 34(5 Pt 2):643-4. PubMed ID: 2877431
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Comparative study, using 3 methods, of the sensitivity to metronidazole and ornidazole of anaerobic or related bacteria].
    Gallusser A
    Ann Microbiol (Paris); 1983; 134B(2):307-21. PubMed ID: 6651124
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparative susceptibilities of anaerobic bacteria to metronidazole, ornidazole, and SC-28538.
    Goldstein EJ; Sutter VL; Finegold SM
    Antimicrob Agents Chemother; 1978 Oct; 14(4):609-13. PubMed ID: 718156
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antimicrobial activity of SMAP-29 against the Bacteroides fragilis group and clostridia.
    Arzese A; Skerlavaj B; Tomasinsig L; Gennaro R; Zanetti M
    J Antimicrob Chemother; 2003 Sep; 52(3):375-81. PubMed ID: 12917245
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Multicentre survey of the in-vitro activity of seven antimicrobial agents, including ertapenem, against recently isolated Gram-negative anaerobic bacteria in Greece.
    Papaparaskevas J; Pantazatou A; Katsandri A; Legakis NJ; Avlamis A;
    Clin Microbiol Infect; 2005 Oct; 11(10):820-4. PubMed ID: 16153256
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In vitro activity of moxifloxacin against 923 anaerobes isolated from human intra-abdominal infections.
    Goldstein EJ; Citron DM; Warren YA; Tyrrell KL; Merriam CV; Fernandez H
    Antimicrob Agents Chemother; 2006 Jan; 50(1):148-55. PubMed ID: 16377680
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Ornidazole in digestive surgery and surgical intensive care (author's transl)].
    Delhumeau A; Carbonnelle B; Chambreuil C; L'Hoste F; Cavellat M
    Anesth Analg (Paris); 1981; 38(11-12):689-92. PubMed ID: 7114521
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.